A Phase I Clinical Trial to Evaluate the Pharmacokinetic and Safety of Ammoxetine Hydrochloride Enteric-Coated Tablets in Participants With Mild Hepatic Impairment, Moderate Hepatic Impairment, and Normal Liver Function

Clinical trial NCT07694843 · RECRUITING

Trial details

NCT number: NCT07694843
Sponsor: CSPC ZhongQi Pharmaceutical Technology Co., Ltd.
Status: RECRUITING
Phase: Phase 1
Study type: INTERVENTIONAL

Healthy Participants Participants With Mild Hepatic Impairment Participants With Moderate Hepatic Impairment

Start date: 2026-03-30
Primary completion: 2026-10-31
Enrollment: 24

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.